Foghorn Therapeutics (FHTX) Debt to Equity: 2020
- Foghorn Therapeutics' Debt to Equity was N/A to $0.13 in Q4 2020 from the same period last year, while for Dec 2020 it was $0.13, marking a year-over-year change of. This contributed to the annual value of $0.13 for FY2020, which is N/A change from last year.
- According to the latest figures from Q4 2020, Foghorn Therapeutics' Debt to Equity is $0.13, which was up 221.19% from -$0.11 recorded in Q3 2020.
- Foghorn Therapeutics' Debt to Equity's 5-year high stood at $0.13 during Q4 2020, with a 5-year trough of -$0.11 in Q3 2020.
- In the last 1 years, Foghorn Therapeutics' Debt to Equity had a median value of $0.01 in 2020 and averaged $0.01.
